Jacobs Levy Equity Management, Inc Uro Gen Pharma Ltd. Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $194,415 - $411,868	-21,530 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.31 - $18.39 $114,222 - $146,788	7,982 Added 58.92%	21,530 $362,000
Q2 2021 Aug 16, 2021	BUY	$15.2 - $20.94 $205,929 - $283,695	13,548 New	13,548 $207,000

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.